Everyone age 65 or more;
People with chronic diseases of the heart;
People with chronic diseases of the lung;
People with chronic diseases of the kidneys;
People with diabetes;
People with immunosuppression;
People with severe forms of anemia;
Residents of nursing homes and other chronic-care facilities;
Children and teenagers receiving long-term aspirin therapy (who may therefore be at risk for developing Reye syndrome after an influenza virus infection);
People in close or frequent contact with anyone at high risk.
People with an allergy to eggs should not receive influenza vaccine.
- Vaccine, killed polio
Polio vaccine, inactivated.
- Vaccine, meningococcal
1906-1910) showed that college students who live on campus have triple the risk of acquiring meningococcal infection compared with their peers who live off-campus. Among the factors cited for a higher risk of the disease on campus were the relative crowding associated with dormitory residence, alcohol-related behaviors, and exposure to tobacco smoke. The same factors […]
- Vaccine, rubella
A vaccine designed to prevent rubella, or German measles. German measles was once seen merely as a child’s unpleasant rite of passage. It was thought to be a mild malady that was usually over and done in three days. So what? Then an outbreak of rubella began in 1964. It lasted two years and infected […]
- Vaccine, Sabin
The oral polio vaccine (OPV) developed by the Polish-born American microbiologist Albert B. Sabin (1906-93).
- Vaccine, Salk
Vaccine against poliomyelitis named for Dr. Jonas Salk who developed and introduced it in 1955. It was the first type of polio vaccine to become available. It was made by cultivating three strains of the virus separately in monkey tissue. The virus was separated from the tissue, stored for a week, and killed with formaldehyde. […]